Goldman Sachs calls for $37bn UK funding to develop new antibiotics
A British government-backed review released on Thursday (14 May) is seeking billions of dollars to fund the development of 15 new antibiotics to counter antibiotic resistance.
World's first malaria vaccine moves closer to use in Africa
The world's first malaria vaccine – made by GlaxoSmithKline – could be approved for use in Africa.
Meningitis vaccine for every new UK baby announced by health secretary Jeremy Hunt
Every child aged two months to receive vaccination following government deal with GlaxoSmithKline.
GSK offloads half its stake in Aspen Pharma for about £570m
Sale of 28.2 million ordinary shares in Aspen Pharma was conducted through a placing at a discounted price.
GlaxoSmithKline to drive Asian business from new Singapore headquarters
GSK plans to move into a new global headquarters for Asia, located in Singapore, in 2017.
GSK sells Australian opiates business to India's Sun Pharma
Firms did not divulge financial details but said they expect to close the deal by August.
Novartis and GSK complete $20bn transactions to reform both firms
GSK and Novartis have completed several transactions totalling $20bn.
GSK profits down in 2014 after China bribery scandal
Drug firm GlaxoSmithKline paid £300m after being found guilty of bribery in China.
Ebola vaccine found safe but immune response lower than expected
Vaccine from GlaxoSmithKline did not create any adverse reactions in recipients.
UK shareholders to receive £85.3bn in dividends in 2015
Additional one-off payouts are set to be paid out by Britain's biggest firms.
Margareta Pagano: David Cameron's Algeria courtship reveals African gem gleaming with opportunity
Algeria has a wealth of business opportunities that Britain can, and is, ready to snap up.
WHO report: Malaria deaths have halved since 2000
Number of deaths from malaria have fallen by 47% since 2000.
GlaxoSmithKline to lay off hundreds of US workers as part of £1bn cost-cutting drive
Company's Research Triangle Park site in North Carolina would be most affected with about 900 redundant jobs.
Apollo to Bid for All of GSK's Mature Drugs Worth Over $3bn
Other bidders are looking to acquire certain regional businesses.
Kate Middleton Reveals Pregnancy Frustration as she Tours Athletes Training Centre
The Duchess of Cambridge met with young athletes at the GSK Human Performance Lab in Essex.
Swiss Test GSK Ebola Vaccine on Volunteers Going to Africa
Switzerland's drug regulator said on Tuesday (October 28) it had approved the testing of an experimental Ebola vaccine from GlaxoSmithKline on healthy volunteers, some of whom will be travelling to West Africa as medical staff.
Ebola: Guinean Government Compensates Families of Deceased Health Workers
The families of 42 health workers will receive $10,000.
Dr Moncef Slaoui: Is This The Man Who Can Save the World from Ebola?
Dr Moncef Slaoui will head the Ebola vaccine development as chairman of vaccines at GlaxoSmithKline
Ebola Outbreak: GlaxoSmithKline Claims It Will Have Vaccine Within Two Months
Healthcare workers on the frontline will be offered initial stock of the vaccine.
Ebola: GlaxoSmithKline Vaccine May Not Be Available During Present Epidemic
Safety and efficiency testing taking time delaying availability of vaccine.
Three Novartis Executives to Leave After Eli Lilly and GSK Deals
George Gunn, Brian McNamara and Andrin Oswald, members of Novartis executive committee, will leave firm.
RBS Confirms Chairman Sir Philip Hampton is Leaving for GlaxoSmithKline
Hampton will join GSK in January 2015 as a non-executive director before assuming chairman's role.
RBS Chairman Sir Philip Hampton to Join GlaxoSmithKline
Rumours circulated last month about Hampton joining the pharmaceutical group
GlaxoSmithKline China Ex-Boss Mark Reilly to Be Deported to UK after Guilty Plea
Mark Reilly, given three-year suspended prison sentence by Chinese court, not to face jail time.
GSK Statement of Apology to the People of China - Full Text
GSK posts apology on its China website after its China subsidiary found guilty of bribery.
GlaxoSmithKline Fined £297m in China for Bribery
GSK's China subsidiary was found guilty of bribing non-government personnel for commercial gains.
Ebola Outbreak: First British Volunteer Receives Experimental Vaccine in Oxford Trial
The first trial of an experimental Ebola vaccine is taking place at the University of Oxford
GSK's China Consumer Healthcare Unit was Probed by US Authorities
GSK in 2012 conducted focused investigation into specific people and suppliers in China in connection with US probe.
GSK's Experimental Ebola Vaccine Approved for Testing on Humans
GSK is developing the vaccine with the Vaccine Research Centre of America's National Institutes of Health.
GlaxoSmithKline Faces Fresh Bribery Allegations in Syria
Company allegedly paid bribes to doctors and officials in cash and kind.